4 mg nicotine lozenge

DRUG2 trials

Sponsors

GlaxoSmithKline, McNeil AB

Conditions

Healthy Volunteer SmokersTobacco Dependence

Phase 1

A Single Dose Bioequivalence Study OfTwo Formulations Of Nicotine Lozenges

CompletedNCT00651352

GlaxoSmithKlineHealthy Volunteer Smokers

Start: 2008-02-29End: 2008-03-31Updated: 2014-11-24

Unknown Phase

Single-dose Nicotine Pharmacokinetics With Four Oral Nicotine Replacement Products

CompletedNCT01234896

McNeil ABTobacco Dependence

Start: 2010-10-31End: 2010-12-31Updated: 2012-07-10